Glenn Welling
Q2 2026 versus Q1 2026: 2 bought, 1 added to, 4 reduced, 0 sold. By dollars, the largest buy was Freshpet Inc, $28.7M more at the quarter-end price; the largest sale Yeti Hldgs Inc, $29.2M less. Net, $16.4M more sold than bought. What every tracked investor did in Q2 2026.
Every move, largest first
| Ticker | Issuer | Move | Shares Q1 2026 → Q2 2026 | Bought / sold | Of the portfolio | Weight now | Price vs model |
|---|---|---|---|---|---|---|---|
| YETI | Yeti Hldgs INC | reduced −33% | 1.8M → 1.2M | −$29.2M | −8.94% | 18.1% | — |
| FRPT | Freshpet INC | bought | — → 484,741 | +$28.7M | +8.76% | 8.8% | — |
| BL | Blackline INC | reduced −39% | 1.4M → 827,619 | −$15.2M | −4.63% | 7.1% | — |
| CGNX | Cognex Corp | reduced −30% | 484,000 → 339,000 | −$10.5M | −3.21% | 7.5% | — |
| GXO | Gxo Logistics Incorporated | added +20% | 821,769 → 984,769 | +$8.3M | +2.53% | 15.3% | — |
| EVH 3.5 12/01/29 | Evolent Health INC | bought | — → 5.5M | +$4.2M | +1.27% | 1.3% | — |
| VFC | V F Corp | reduced −3% | 4.7M → 4.5M | −$2.6M | −0.80% | 23.1% | — |
Bought / sold is the change in shares × the quarter's reported price (value ÷ shares in the filing); a position sold out is priced at the quarter before, since it has no price in this one. “Of the portfolio” is that amount against this quarter's reported book.
Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.